Your browser doesn't support javascript.
loading
Hydralazine decreases blood pressure and endothelin-1 mRNA expression in tissues but not cardiac weight in SHR-SP/Izm rats.
Tanabe, A; Naruse, M; Adachi, C; Seki, T; Yoshimoto, T; Takagi, S; Naruse, K; Takano, K.
Affiliation
  • Tanabe A; Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, Japan. RXK00525@niftyserve.or.jp
J Cardiovasc Pharmacol ; 36(5 Suppl 1): S176-8, 2000 Nov.
Article in En | MEDLINE | ID: mdl-11078370
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Pressure / RNA, Messenger / Cardiomegaly / Endothelin-1 / Hydralazine / Antihypertensive Agents Limits: Animals Language: En Journal: J Cardiovasc Pharmacol Year: 2000 Document type: Article Affiliation country: Japón
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Pressure / RNA, Messenger / Cardiomegaly / Endothelin-1 / Hydralazine / Antihypertensive Agents Limits: Animals Language: En Journal: J Cardiovasc Pharmacol Year: 2000 Document type: Article Affiliation country: Japón